Streetbeat News

Stock Prices

BMY

Bristol-Myers Squibb Inc. (NYSE:BMY) has seen its shares decrease by 11.11% in the past three months. The company's financial statement as of April 27, 2023, shows a long-term debt of $35.08 billion and current debt of $2.75 billion, amounting to $37.83 billion in total debt. After adjusting for $8.99 billion in cash-equivalents, the company's net debt stands at $28.84 billion. The company's debt-ratio is 0.4, indicating a moderate level of financial leverage.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 4:15 pm

BILL

Goldman Sachs has raised its price target on BILL Holdings from $115 to $136, leading to an increase in the company's stock trading.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 4:14 pm

GGAA

Shares of Genesis Growth Tech Acquisition Corp. (GGAA) resumed trading, only to be halted again due to a circuit breaker. The stock is now up by 71.9%.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 4:10 pm

BLK

BRPHF

BTCUSD

Galaxy Digital Holdings Ltd. CEO, Mike Novogratz, predicts a rise in Bitcoin's value by the end of the year and anticipates the approval of Bitcoin ETFs in the U.S. This growth is largely attributed to the anticipation of a potential US approval of a Bitcoin ETF. The approval of a Bitcoin ETF will lead to widespread adoption of Bitcoin by investors through firms like BlackRock Inc. and Invesco. Galaxy, currently listed in Toronto, is working towards becoming a Delaware-incorporated company and plans to list on the Nasdaq, pending an ongoing review by the SEC.

Portfolio Pulse from Murtuza Merchant

July 13, 2023 | 4:09 pm

GOOG

GOOGL

Alphabet has launched its Bard AI chatbot in Europe and Brazil, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 4:04 pm

NVEI

Analysts have provided bullish and somewhat bullish ratings for Nuvei (NASDAQ:NVEI) in the last quarter. In the last 3 months, 7 analysts have offered 12-month price targets for Nuvei, with an average price target of $48.43. The average price target has increased by 0.48% over the past month.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 4:01 pm

TXG

Over the past 3 months, 10x Genomics (NASDAQ:TXG) has been rated by 7 analysts, with 2 being bullish, 4 somewhat bullish, and 1 bearish. The average 12-month price target for the stock has increased by 19.94% from the previous average, now standing at $60.57.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 4:01 pm

IGT

Analysts have provided bullish and somewhat bullish ratings for Intl Game Tech (NYSE:IGT) in the last quarter. According to 5 analysts offering 12-month price targets in the last 3 months, Intl Game Tech has an average price target of $36.4, an increase of 24.11% from the previous average price target of $29.33.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 4:01 pm

ACN

Accenture (NYSE:ACN) has outperformed the market over the past 10 years by 5.11% on an annualized basis, producing an average annual return of 15.42%. If an investor had bought $100 of ACN stock 10 years ago, it would be worth $418.90 today.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 4:00 pm

PPC

Pilgrim's Pride Corp (PPC) has been upgraded to Outperform from Market Perform by BMO Capital Markets analyst Andrew Strelzik, with a price target of $28, up from $26. The upgrade is due to increased investor optimism following the announcement of PPC's acquisition by JBS Food Group. The acquisition is expected to limit the downside related to the softer U.S. chicken margin environment. Lower feed costs and potential improvement in supply/demand are expected to benefit PPC's U.S. chicken margins and drive increased chicken prices.

Portfolio Pulse from Lekha Gupta

July 13, 2023 | 4:00 pm